NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 41 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $249,877 | +18.6% | 301,057 | 0.0% | 0.00% | – |
| Q1 2023 | $210,739 | +137637.9% | 301,057 | 0.0% | 0.00% | – |
| Q4 2022 | $153 | -99.9% | 301,057 | -0.2% | 0.00% | – |
| Q3 2022 | $193,000 | -37.7% | 301,783 | 0.0% | 0.00% | – |
| Q2 2022 | $310,000 | -71.9% | 301,783 | -48.5% | 0.00% | – |
| Q1 2022 | $1,102,000 | -61.1% | 586,508 | -0.3% | 0.00% | – |
| Q4 2021 | $2,834,000 | -36.5% | 588,139 | -4.8% | 0.00% | -100.0% |
| Q3 2021 | $4,466,000 | -16.9% | 617,827 | +6.0% | 0.00% | 0.0% |
| Q2 2021 | $5,377,000 | -18.7% | 582,625 | +8.4% | 0.00% | 0.0% |
| Q1 2021 | $6,613,000 | -1.3% | 537,242 | +13.0% | 0.00% | 0.0% |
| Q4 2020 | $6,701,000 | +25.8% | 475,306 | +7.0% | 0.00% | 0.0% |
| Q3 2020 | $5,328,000 | -26.5% | 444,051 | +1.7% | 0.00% | -50.0% |
| Q2 2020 | $7,245,000 | +118.9% | 436,481 | +50.0% | 0.00% | +100.0% |
| Q1 2020 | $3,310,000 | -50.6% | 290,900 | -46.6% | 0.00% | 0.0% |
| Q4 2019 | $6,706,000 | +1279.8% | 544,418 | +219.1% | 0.00% | – |
| Q3 2019 | $486,000 | – | 170,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |